Spectratype analysis of clonal T cell expansion in murine experimental stroke

Journal of Neuroimmunology

Volumn 257, Issue 1-2, 2013, Pages 46-52

  Liesz, Arthur ^a   Karcher, Simone ^a   Veltkamp, Roland ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Clonality; Neuroinflammation; Spectratyping; Stroke; T cell receptor

Indexed keywords

T LYMPHOCYTE RECEPTOR;

ANALYTIC METHOD; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN INFARCTION SIZE; BRAIN ISCHEMIA; CELL ASSAY; CELL EXPANSION; CELL INVASION; CELL ISOLATION; CELLULAR DISTRIBUTION; CLONAL T CELL EXPANSION; CLONAL VARIATION; CONTROLLED STUDY; GENE; LYMPHOCYTE COUNT; MALE; MOUSE; NERVOUS SYSTEM INFLAMMATION; NONHUMAN; PRIORITY JOURNAL; SPECTRATYPE ANALYSIS; T LYMPHOCYTE ACTIVATION; VBETA GENE;

ANIMALS; CELL DIFFERENTIATION; CLONE CELLS; DISEASE MODELS, ANIMAL; LYMPHOCYTE ACTIVATION; MALE; MICE; MICE, INBRED C57BL; SPECTRAL KARYOTYPING; STROKE; T-LYMPHOCYTE SUBSETS;

EID: 84875812958     PISSN: 01655728     EISSN: 18728421     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2013.01.013     Document Type: Article

References (31)

1. Becker K.J., McCarron R.M., Ruetzler C., Laban O., Sternberg E., Flanders K.C., Hallenbeck J.M. Immunologic tolerance to myelin basic protein decreases stroke size after transient focal cerebral ischemia. Proc. Natl. Acad. Sci. U.S.A. 1997, 94:10873-10878.
2. Benichou J., Ben-Hamo R., Louzoun Y., Efroni S. Rep-Seq: uncovering the immunological repertoire through next-generation sequencing. Immunology 2012, 135:183-191.
3. Brait V.H., Arumugam T.V., Drummond G.R., Sobey C.G. Importance of T lymphocytes in brain injury, immunodeficiency, and recovery after cerebral ischemia. J. Cereb. Blood Flow Metab. 2012, 32:598-611.
4. Currier J.R., Robinson M.A. Spectratype/immunoscope analysis of the expressed TCR repertoire. Curr. Protoc. Immunol. 2001, (May; Chapter 10: Unit 10.28).
5. Davis M.M., Boniface J.J., Reich Z., Lyons D., Hampl J., Arden B., Chien Y. Ligand recognition by alpha beta T cell receptors. Annu. Rev. Immunol. 1998, 16:523-544.
6. Dirnagl U. Inflammation in stroke: the good, the bad, and the unknown. Ernst Schering Res. Found. Workshop 2004, 87-99.
7. Felger J.C., Abe T., Kaunzner U.W., Gottfried-Blackmore A., Gal-Toth J., McEwen B.S., Iadecola C., Bulloch K. Brain dendritic cells in ischemic stroke: time course, activation state, and origin. Brain Behav. Immun. 2010, 24:724-737.
8. Frenkel D., Huang Z., Maron R., Koldzic D.N., Moskowitz M.A., Weiner H.L. Neuroprotection by IL-10-producing MOG CD4+ T cells following ischemic stroke. J. Neurol. Sci. 2005, 233:125-132.
9. Gelderblom M., Leypoldt F., Steinbach K., Behrens D., Choe C.-U., Siler D.a, Arumugam T.V., Orthey E., Gerloff C., Tolosa E., Magnus T. Temporal and spatial dynamics of cerebral immune cell accumulation in stroke. Stroke 2009, 40:1849-1857.
10. Gelderblom M., Weymar A., Bernreuther C., Velden J., Arunachalam P., Steinbach K., Orthey E., Arumugam T.V., Lyepoldt F., Simova O., Thom V., Friese M.A., Prinz I., Hoelscher C., Glatzel M., Korn T., Gerloff C., Tolosa E., Magnus T. Neutralization of the IL-17 axis diminishes neutrophil invasion and protects from ischemic stroke. Blood 2012, 120:3793-3802.
11. Hossmann K.A. The two pathophysiologies of focal brain ischemia: implications for translational stroke research. J. Cereb. Blood Flow Metab. 2012, 32:1310-1316.
12. Iadecola C., Anrather J. The immunology of stroke: from mechanisms to translation. Nat. Med. 2011, 17:796-808.
13. Jenkins M.K., Khoruts A., Ingulli E., Mueller D.L., McSorley S.J., Reinhardt R.L., Itano A., Pape K.A. In vivo activation of antigen-specific CD4 T cells. Annu. Rev. Immunol. 2001, 19:23-45.
14. Jorgensen J.L., Esser U., de St Fazekas, Groth B., Reay P.A., Davis M.M. Mapping T-cell receptor-peptide contacts by variant peptide immunization of single-chain transgenics. Nature 1992, 355:224-230.
15. Kleinschnitz C., Schwab N., Kraft P., Hagedorn I., Dreykluft A., Schwarz T., Austinat M., Nieswandt B., Wiendl H., Stoll G. Early detrimental T-cell effects in experimental cerebral ischemia are neither related to adaptive immunity nor thrombus formation. Blood 2010, 115:3835-3842.
16. Liesz A., Suri-Payer E., Veltkamp C., Doerr H., Sommer C., Rivest S., Giese T., Veltkamp R. Regulatory T cells are key cerebroprotective immunomodulators in acute experimental stroke. Nat. Med. 2009, 15:192-199.
17. Liesz A., Zhou W., Mracsko E., Karcher S., Bauer H., Schwarting S., Sun L., Bruder D., Stegemann S., Cerwenka A., Sommer C., Dalpke A.H., Veltkamp R. Inhibition of lymphocyte trafficking shields the brain against deleterious neuroinflammation after stroke. Brain 2011, 134:704-720.
18. Maecker H.T., Lindstrom T.M., Robinson W.H., Utz P.J., Hale M., Boyd S.D., Shen-Orr S.S., Fathman C.G. New tools for classification and monitoring of autoimmune diseases. Nat. Rev. Rheumatol. 2012, 8:317-328.
19. Matsumoto Y. Characterization of T cell receptor (TCR) of organ-specific autoimmune disease-inducing T cells and TCR-based immunotherapy with DNA vaccines. J. Neuroimmunol. 2000, 110:1-12.
20. Nathan C., Ding A. Nonresolving inflammation. Cell 2010, 140:871-882.
21. Nikolich-Zugich J., Slifka M.K., Messaoudi I. The many important facets of T-cell repertoire diversity. Nat. Rev. Immunol. 2004, 4:123-132.
22. Planas A.M., Gomez-Choco M., Urra X., Gorina R., Caballero M., Chamorro A. Brain-derived antigens in lymphoid tissue of patients with acute stroke. J. Immunol. 2012, 188:2156-2163.
23. Reijonen H., Kwok W.W. Use of HLA class II tetramers in tracking antigen-specific T cells and mapping T-cell epitopes. Methods 2003, 29:282-288.
24. Shichita T., Sugiyama Y., Ooboshi H., Sugimori H., Nakagawa R., Takada I., Iwaki T., Okada Y., Iida M., Cua D.J., Iwakura Y., Yoshimura A. Pivotal role of cerebral interleukin-17-producing gammadeltaT cells in the delayed phase of ischemic brain injury. Nat. Med. 2009, 15:946-950.
25. Stubbe T., Ebner F., Richter D., Randolf Engel O., Klehmet J., Royl G., Meisel A., Nitsch R., Meisel C., Brandt C. Regulatory T cells accumulate and proliferate in the ischemic hemisphere for up to 30days after MCAO. J. Cereb. Blood Flow Metab. 2013, 33(1):37-47. (Jan).
26. Subramanian S., Zhang B., Kosaka Y., Burrows G.G., Grafe M.R., Vandenbark A.A., Hurn P.D., Offner H. Recombinant T cell receptor ligand treats experimental stroke. Stroke 2009, 40:2539-2545.
27. Tamura A., Graham D.I., McCulloch J., Teasdale G.M. Focal cerebral ischaemia in the rat: 1. Description of technique and early neuropathological consequences following middle cerebral artery occlusion. J. Cereb. Blood Flow Metab. 1981, 1:53-60.
28. Wang W.Z., Olsson T., Kostulas V., Hojeberg B., Ekre H.P., Link H. Myelin antigen reactive T cells in cerebrovascular diseases. Clin. Exp. Immunol. 1992, 88:157-162.
29. Wang Q., Tang X.N., Yenari M.A. The inflammatory response in stroke. J. Neuroimmunol. 2006, 184:53-68.
30. Yilmaz G., Arumugam T.V., Stokes K.Y., Granger D.N. Role of T lymphocytes and interferon-gamma in ischemic stroke. Circulation 2006, 113:2105-2112.
31. Zhou W., Liesz A., Bauer H., Sommer C., Lahrmann B., Valous N., Grabe N., Veltkamp R. Postischemic brain infiltration of leukocyte subpopulations differs among murine permanent and transient focal cerebral ischemia models. Brain Pathol. 2013, 23(1):34-44. (Jan).